NCT05844826View on ClinicalTrials.gov

Evaluation of the Microbiome in Multiple Sclerosis

NATerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

April 24, 2024

Study Completion Date

April 24, 2024

Conditions
Multiple Sclerosis
Interventions
DEVICE

SIMBA Capsule

Participants will swallow capsule

Trial Locations (1)

T2N 1N4

University of Calgary, Calgary

Sponsors

Collaborators (1)

IGY Life Sciences
All Listed Sponsors
collaborator

IGY Life Sciences

UNKNOWN

lead

Nimble Science Ltd.

INDUSTRY